Date of Publish: 09/08/2006

LTT-MELISA® is clinically relevant for detecting and monitoring metal sensitivity

Valentine-Thon E, Muller K, Guzzi G, Kreisel S, Ohnsorge P, Sandkamp M. Neuro Endocrinol Lett 2006; 27(Suppl 1): 17-24
Blood from 700 consecutive patients was tested against a total of 26 metals in the validated LTT-MELISA®. For reproducibility testing, 391 single metal tests from 63 patients were performed in parallel. Finally, to assess clinical relevance, 14 patients with known metal exposure showing local (dry mouth, Oral Lichen Planus, Burning Mouth Syndrome, eczema) and/or systemic (chronic infections, fatigue, autoimmune disorders, central nervous system disturbances, depression) effects were tested and their cases reported.

Click HERE to go back to listing page.